Psyence Biomedical
6 hedge funds and large institutions have $764K invested in Psyence Biomedical in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
22% more capital invested
Capital invested by funds: $625K → $764K (+$138K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
7.11% less ownership
Funds ownership: 8.61% → 1.5% (-7.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$45.4K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$19.8K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$4.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Parallel Advisors
San Francisco,
California
|
-$544K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$108K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Parallel Advisors
San Francisco,
California
| $687K | -$544K | -19,800 | -45% |
|
|
VF
2
Virtu Financial
New York
| $33K | +$45.4K | +1,652 | New |
|
|
AI
3
AdvisorShares Investments
Bethesda,
Maryland
| $17.2K | +$4.07K | +148 | +21% |
|
|
4
Osaic Holdings
Scottsdale,
Arizona
| $14.4K | +$19.8K | +720 | New |
|
5
Bank of America
Charlotte,
North Carolina
| $10.7K | – | – | – |
|
|
SFFS
6
Stonehage Fleming Financial Services
St. Helier,
Jersey
| $1.79K | – | – | – |
|
|
SM
7
Sabby Management
Miami Beach,
Florida
| – | -$108K | -3,252 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$10.4K | -313 | Closed |
|
PBM Hedge Fund Activity: Q3 2025 in Review
6 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2025, worth a combined $764K — up 22% from $625K a quarter earlier.
Fund positioning in PBM was balanced in Q3 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $45.4K. The largest seller was Parallel Advisors, cutting an estimated $544K.
- 6 institutional investors held Psyence Biomedical (PBM) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $764K of Psyence Biomedical stock for Q3 2025, up 22% quarter-over-quarter.
- 2 funds opened new Psyence Biomedical positions in Q3 2025 and 2 closed out, a net change of 0 holders.
- The largest Psyence Biomedical buyer in Q3 2025 was Virtu Financial, an estimated $45.4K added.
- The largest Psyence Biomedical seller in Q3 2025 was Parallel Advisors, an estimated $544K sold.
Based on aggregated 13F filings for Q3 2025.